Mersana Therapeutics, Inc. Long-Term Debt, Maturity, Year Four
Mersana Therapeutics, Inc. had Long-Term Debt, Maturity, Year Four of $10.42 million as of 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour · last filed 2023-02-28
- 2022-12-31: Long-Term Debt, Maturity, Year Four $10.42M.
- 2021-12-31: Long-Term Debt, Maturity, Year Four $12.50M.
- 2020-12-31: Long-Term Debt, Maturity, Year Four $1.91M.
- 2020-09-30: Long-Term Debt, Maturity, Year Four $1.91M.
| Period end | Long-Term Debt, Maturity, Year Four |
|---|---|
| 2022-12-31 | $10.42M 10-K · filed 2023-02-28 |
| 2021-12-31 | $12.50M 10-K · filed 2022-02-28 |
| 2020-12-31 | $1.91M 10-K · filed 2021-02-26 |
| 2020-09-30 | $1.91M 10-Q · filed 2020-11-09 |
| 2020-03-31 | $333.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $333.00K 10-K · filed 2020-02-28 |
| 2019-09-30 | $2.00M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.00M 10-Q · filed 2019-08-08 |